Patient-reported outcomes in CodeBreak 200: Sotorasib versus docetaxel for previously treated advanced NSCLC with KRAS G12C mutation
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list 
StoryNote Upvotes: 1